ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Computational Medicine and Drug Discovery Software Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-10M8711
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
China Computational Medicine and Drug Discovery Software Market Report Forecast 2021 2027
BUY CHAPTERS

Global Computational Medicine and Drug Discovery Software Market Research Report 2025

Code: QYRE-Auto-10M8711
Report
September 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Entelos Inc
Genedata Ag
Crown Bioscience
Biognos Ab
Chemical Computing Group
Leadscope Inc
Nimbus Therapeutics
Rhenovia Pharma Limited
Schrodinger Llc
Compugen
Dassault Systemes

Computational Medicine and Drug Discovery Software Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Computational Medicine and Drug Discovery Software Market

Computational Medicine and Drug Discovery Software Market

The global market for Computational Medicine and Drug Discovery Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Computational Medicine finds its roots in chemistry and quantum mechanics. The foundation of computational medicine is based upon database and constraint-based models.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Computational Medicine and Drug Discovery Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Medicine and Drug Discovery Software.
The Computational Medicine and Drug Discovery Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Computational Medicine and Drug Discovery Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computational Medicine and Drug Discovery Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Computational Medicine and Drug Discovery Software Market Report

Report Metric Details
Report Name Computational Medicine and Drug Discovery Software Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Database
  • Software
  • Others
Segment by Application
  • Computational Physiological Medicine
  • Drug Discovery And Development
  • Medical Imaging
  • Disease Modeling
  • Predictive Analysis Of Drug Targets
  • Cellular Simulation
  • Simulation Software
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Entelos, Genedata, Crown Bioscience, Biognos, Chemical Computing Group, Leadscope, Nimbus Therapeutics, Rhenovia Pharma Limited, Schrodinger, Compugen, Dassault Systemes
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Computational Medicine and Drug Discovery Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Computational Medicine and Drug Discovery Software Market report?

Ans: The main players in the Computational Medicine and Drug Discovery Software Market are Entelos, Genedata, Crown Bioscience, Biognos, Chemical Computing Group, Leadscope, Nimbus Therapeutics, Rhenovia Pharma Limited, Schrodinger, Compugen, Dassault Systemes

What are the Application segmentation covered in the Computational Medicine and Drug Discovery Software Market report?

Ans: The Applications covered in the Computational Medicine and Drug Discovery Software Market report are Computational Physiological Medicine, Drug Discovery And Development, Medical Imaging, Disease Modeling, Predictive Analysis Of Drug Targets, Cellular Simulation, Simulation Software

What are the Type segmentation covered in the Computational Medicine and Drug Discovery Software Market report?

Ans: The Types covered in the Computational Medicine and Drug Discovery Software Market report are Database, Software, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Medicine and Drug Discovery Software Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Database
1.2.3 Software
1.2.4 Others
1.3 Market by Application
1.3.1 Global Computational Medicine and Drug Discovery Software Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Computational Physiological Medicine
1.3.3 Drug Discovery And Development
1.3.4 Medical Imaging
1.3.5 Disease Modeling
1.3.6 Predictive Analysis Of Drug Targets
1.3.7 Cellular Simulation
1.3.8 Simulation Software
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computational Medicine and Drug Discovery Software Market Perspective (2020-2031)
2.2 Global Computational Medicine and Drug Discovery Software Growth Trends by Region
2.2.1 Global Computational Medicine and Drug Discovery Software Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Computational Medicine and Drug Discovery Software Historic Market Size by Region (2020-2025)
2.2.3 Computational Medicine and Drug Discovery Software Forecasted Market Size by Region (2026-2031)
2.3 Computational Medicine and Drug Discovery Software Market Dynamics
2.3.1 Computational Medicine and Drug Discovery Software Industry Trends
2.3.2 Computational Medicine and Drug Discovery Software Market Drivers
2.3.3 Computational Medicine and Drug Discovery Software Market Challenges
2.3.4 Computational Medicine and Drug Discovery Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computational Medicine and Drug Discovery Software Players by Revenue
3.1.1 Global Top Computational Medicine and Drug Discovery Software Players by Revenue (2020-2025)
3.1.2 Global Computational Medicine and Drug Discovery Software Revenue Market Share by Players (2020-2025)
3.2 Global Computational Medicine and Drug Discovery Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Computational Medicine and Drug Discovery Software Revenue
3.4 Global Computational Medicine and Drug Discovery Software Market Concentration Ratio
3.4.1 Global Computational Medicine and Drug Discovery Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Medicine and Drug Discovery Software Revenue in 2024
3.5 Global Key Players of Computational Medicine and Drug Discovery Software Head office and Area Served
3.6 Global Key Players of Computational Medicine and Drug Discovery Software, Product and Application
3.7 Global Key Players of Computational Medicine and Drug Discovery Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Medicine and Drug Discovery Software Breakdown Data by Type
4.1 Global Computational Medicine and Drug Discovery Software Historic Market Size by Type (2020-2025)
4.2 Global Computational Medicine and Drug Discovery Software Forecasted Market Size by Type (2026-2031)
5 Computational Medicine and Drug Discovery Software Breakdown Data by Application
5.1 Global Computational Medicine and Drug Discovery Software Historic Market Size by Application (2020-2025)
5.2 Global Computational Medicine and Drug Discovery Software Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Computational Medicine and Drug Discovery Software Market Size (2020-2031)
6.2 North America Computational Medicine and Drug Discovery Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Computational Medicine and Drug Discovery Software Market Size by Country (2020-2025)
6.4 North America Computational Medicine and Drug Discovery Software Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computational Medicine and Drug Discovery Software Market Size (2020-2031)
7.2 Europe Computational Medicine and Drug Discovery Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Computational Medicine and Drug Discovery Software Market Size by Country (2020-2025)
7.4 Europe Computational Medicine and Drug Discovery Software Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computational Medicine and Drug Discovery Software Market Size (2020-2031)
8.2 Asia-Pacific Computational Medicine and Drug Discovery Software Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Computational Medicine and Drug Discovery Software Market Size by Region (2020-2025)
8.4 Asia-Pacific Computational Medicine and Drug Discovery Software Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computational Medicine and Drug Discovery Software Market Size (2020-2031)
9.2 Latin America Computational Medicine and Drug Discovery Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Computational Medicine and Drug Discovery Software Market Size by Country (2020-2025)
9.4 Latin America Computational Medicine and Drug Discovery Software Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computational Medicine and Drug Discovery Software Market Size (2020-2031)
10.2 Middle East & Africa Computational Medicine and Drug Discovery Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Computational Medicine and Drug Discovery Software Market Size by Country (2020-2025)
10.4 Middle East & Africa Computational Medicine and Drug Discovery Software Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Entelos
11.1.1 Entelos Company Details
11.1.2 Entelos Business Overview
11.1.3 Entelos Computational Medicine and Drug Discovery Software Introduction
11.1.4 Entelos Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025)
11.1.5 Entelos Recent Development
11.2 Genedata
11.2.1 Genedata Company Details
11.2.2 Genedata Business Overview
11.2.3 Genedata Computational Medicine and Drug Discovery Software Introduction
11.2.4 Genedata Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025)
11.2.5 Genedata Recent Development
11.3 Crown Bioscience
11.3.1 Crown Bioscience Company Details
11.3.2 Crown Bioscience Business Overview
11.3.3 Crown Bioscience Computational Medicine and Drug Discovery Software Introduction
11.3.4 Crown Bioscience Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025)
11.3.5 Crown Bioscience Recent Development
11.4 Biognos
11.4.1 Biognos Company Details
11.4.2 Biognos Business Overview
11.4.3 Biognos Computational Medicine and Drug Discovery Software Introduction
11.4.4 Biognos Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025)
11.4.5 Biognos Recent Development
11.5 Chemical Computing Group
11.5.1 Chemical Computing Group Company Details
11.5.2 Chemical Computing Group Business Overview
11.5.3 Chemical Computing Group Computational Medicine and Drug Discovery Software Introduction
11.5.4 Chemical Computing Group Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025)
11.5.5 Chemical Computing Group Recent Development
11.6 Leadscope
11.6.1 Leadscope Company Details
11.6.2 Leadscope Business Overview
11.6.3 Leadscope Computational Medicine and Drug Discovery Software Introduction
11.6.4 Leadscope Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025)
11.6.5 Leadscope Recent Development
11.7 Nimbus Therapeutics
11.7.1 Nimbus Therapeutics Company Details
11.7.2 Nimbus Therapeutics Business Overview
11.7.3 Nimbus Therapeutics Computational Medicine and Drug Discovery Software Introduction
11.7.4 Nimbus Therapeutics Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025)
11.7.5 Nimbus Therapeutics Recent Development
11.8 Rhenovia Pharma Limited
11.8.1 Rhenovia Pharma Limited Company Details
11.8.2 Rhenovia Pharma Limited Business Overview
11.8.3 Rhenovia Pharma Limited Computational Medicine and Drug Discovery Software Introduction
11.8.4 Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025)
11.8.5 Rhenovia Pharma Limited Recent Development
11.9 Schrodinger
11.9.1 Schrodinger Company Details
11.9.2 Schrodinger Business Overview
11.9.3 Schrodinger Computational Medicine and Drug Discovery Software Introduction
11.9.4 Schrodinger Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025)
11.9.5 Schrodinger Recent Development
11.10 Compugen
11.10.1 Compugen Company Details
11.10.2 Compugen Business Overview
11.10.3 Compugen Computational Medicine and Drug Discovery Software Introduction
11.10.4 Compugen Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025)
11.10.5 Compugen Recent Development
11.11 Dassault Systemes
11.11.1 Dassault Systemes Company Details
11.11.2 Dassault Systemes Business Overview
11.11.3 Dassault Systemes Computational Medicine and Drug Discovery Software Introduction
11.11.4 Dassault Systemes Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025)
11.11.5 Dassault Systemes Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Entelos Inc
Genedata Ag
Crown Bioscience
Biognos Ab
Chemical Computing Group
Leadscope Inc
Nimbus Therapeutics
Rhenovia Pharma Limited
Schrodinger Llc
Compugen
Dassault Systemes
List of Tables
 Table 1. Global Computational Medicine and Drug Discovery Software Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Database
 Table 3. Key Players of Software
 Table 4. Key Players of Others
 Table 5. Global Computational Medicine and Drug Discovery Software Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Computational Medicine and Drug Discovery Software Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Computational Medicine and Drug Discovery Software Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Computational Medicine and Drug Discovery Software Market Share by Region (2020-2025)
 Table 9. Global Computational Medicine and Drug Discovery Software Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Computational Medicine and Drug Discovery Software Market Share by Region (2026-2031)
 Table 11. Computational Medicine and Drug Discovery Software Market Trends
 Table 12. Computational Medicine and Drug Discovery Software Market Drivers
 Table 13. Computational Medicine and Drug Discovery Software Market Challenges
 Table 14. Computational Medicine and Drug Discovery Software Market Restraints
 Table 15. Global Computational Medicine and Drug Discovery Software Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Computational Medicine and Drug Discovery Software Market Share by Players (2020-2025)
 Table 17. Global Top Computational Medicine and Drug Discovery Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Discovery Software as of 2024)
 Table 18. Ranking of Global Top Computational Medicine and Drug Discovery Software Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Computational Medicine and Drug Discovery Software Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Computational Medicine and Drug Discovery Software, Headquarters and Area Served
 Table 21. Global Key Players of Computational Medicine and Drug Discovery Software, Product and Application
 Table 22. Global Key Players of Computational Medicine and Drug Discovery Software, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Computational Medicine and Drug Discovery Software Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Computational Medicine and Drug Discovery Software Revenue Market Share by Type (2020-2025)
 Table 26. Global Computational Medicine and Drug Discovery Software Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Computational Medicine and Drug Discovery Software Revenue Market Share by Type (2026-2031)
 Table 28. Global Computational Medicine and Drug Discovery Software Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Computational Medicine and Drug Discovery Software Revenue Market Share by Application (2020-2025)
 Table 30. Global Computational Medicine and Drug Discovery Software Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Computational Medicine and Drug Discovery Software Revenue Market Share by Application (2026-2031)
 Table 32. North America Computational Medicine and Drug Discovery Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Computational Medicine and Drug Discovery Software Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Computational Medicine and Drug Discovery Software Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Computational Medicine and Drug Discovery Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Computational Medicine and Drug Discovery Software Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Computational Medicine and Drug Discovery Software Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Computational Medicine and Drug Discovery Software Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Computational Medicine and Drug Discovery Software Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Computational Medicine and Drug Discovery Software Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Computational Medicine and Drug Discovery Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Computational Medicine and Drug Discovery Software Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Computational Medicine and Drug Discovery Software Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Computational Medicine and Drug Discovery Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Computational Medicine and Drug Discovery Software Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Computational Medicine and Drug Discovery Software Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Entelos Company Details
 Table 48. Entelos Business Overview
 Table 49. Entelos Computational Medicine and Drug Discovery Software Product
 Table 50. Entelos Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025) & (US$ Million)
 Table 51. Entelos Recent Development
 Table 52. Genedata Company Details
 Table 53. Genedata Business Overview
 Table 54. Genedata Computational Medicine and Drug Discovery Software Product
 Table 55. Genedata Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025) & (US$ Million)
 Table 56. Genedata Recent Development
 Table 57. Crown Bioscience Company Details
 Table 58. Crown Bioscience Business Overview
 Table 59. Crown Bioscience Computational Medicine and Drug Discovery Software Product
 Table 60. Crown Bioscience Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025) & (US$ Million)
 Table 61. Crown Bioscience Recent Development
 Table 62. Biognos Company Details
 Table 63. Biognos Business Overview
 Table 64. Biognos Computational Medicine and Drug Discovery Software Product
 Table 65. Biognos Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025) & (US$ Million)
 Table 66. Biognos Recent Development
 Table 67. Chemical Computing Group Company Details
 Table 68. Chemical Computing Group Business Overview
 Table 69. Chemical Computing Group Computational Medicine and Drug Discovery Software Product
 Table 70. Chemical Computing Group Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025) & (US$ Million)
 Table 71. Chemical Computing Group Recent Development
 Table 72. Leadscope Company Details
 Table 73. Leadscope Business Overview
 Table 74. Leadscope Computational Medicine and Drug Discovery Software Product
 Table 75. Leadscope Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025) & (US$ Million)
 Table 76. Leadscope Recent Development
 Table 77. Nimbus Therapeutics Company Details
 Table 78. Nimbus Therapeutics Business Overview
 Table 79. Nimbus Therapeutics Computational Medicine and Drug Discovery Software Product
 Table 80. Nimbus Therapeutics Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025) & (US$ Million)
 Table 81. Nimbus Therapeutics Recent Development
 Table 82. Rhenovia Pharma Limited Company Details
 Table 83. Rhenovia Pharma Limited Business Overview
 Table 84. Rhenovia Pharma Limited Computational Medicine and Drug Discovery Software Product
 Table 85. Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025) & (US$ Million)
 Table 86. Rhenovia Pharma Limited Recent Development
 Table 87. Schrodinger Company Details
 Table 88. Schrodinger Business Overview
 Table 89. Schrodinger Computational Medicine and Drug Discovery Software Product
 Table 90. Schrodinger Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025) & (US$ Million)
 Table 91. Schrodinger Recent Development
 Table 92. Compugen Company Details
 Table 93. Compugen Business Overview
 Table 94. Compugen Computational Medicine and Drug Discovery Software Product
 Table 95. Compugen Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025) & (US$ Million)
 Table 96. Compugen Recent Development
 Table 97. Dassault Systemes Company Details
 Table 98. Dassault Systemes Business Overview
 Table 99. Dassault Systemes Computational Medicine and Drug Discovery Software Product
 Table 100. Dassault Systemes Revenue in Computational Medicine and Drug Discovery Software Business (2020-2025) & (US$ Million)
 Table 101. Dassault Systemes Recent Development
 Table 102. Research Programs/Design for This Report
 Table 103. Key Data Information from Secondary Sources
 Table 104. Key Data Information from Primary Sources
 Table 105. Authors List of This Report


List of Figures
 Figure 1. Computational Medicine and Drug Discovery Software Picture
 Figure 2. Global Computational Medicine and Drug Discovery Software Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Computational Medicine and Drug Discovery Software Market Share by Type: 2024 VS 2031
 Figure 4. Database Features
 Figure 5. Software Features
 Figure 6. Others Features
 Figure 7. Global Computational Medicine and Drug Discovery Software Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Computational Medicine and Drug Discovery Software Market Share by Application: 2024 VS 2031
 Figure 9. Computational Physiological Medicine Case Studies
 Figure 10. Drug Discovery And Development Case Studies
 Figure 11. Medical Imaging Case Studies
 Figure 12. Disease Modeling Case Studies
 Figure 13. Predictive Analysis Of Drug Targets Case Studies
 Figure 14. Cellular Simulation Case Studies
 Figure 15. Simulation Software Case Studies
 Figure 16. Computational Medicine and Drug Discovery Software Report Years Considered
 Figure 17. Global Computational Medicine and Drug Discovery Software Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Computational Medicine and Drug Discovery Software Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Computational Medicine and Drug Discovery Software Market Share by Region: 2024 VS 2031
 Figure 20. Global Computational Medicine and Drug Discovery Software Market Share by Players in 2024
 Figure 21. Global Top Computational Medicine and Drug Discovery Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Discovery Software as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Computational Medicine and Drug Discovery Software Revenue in 2024
 Figure 23. North America Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Computational Medicine and Drug Discovery Software Market Share by Country (2020-2031)
 Figure 25. United States Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Computational Medicine and Drug Discovery Software Market Share by Country (2020-2031)
 Figure 29. Germany Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Computational Medicine and Drug Discovery Software Market Share by Region (2020-2031)
 Figure 37. China Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Computational Medicine and Drug Discovery Software Market Share by Country (2020-2031)
 Figure 45. Mexico Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Computational Medicine and Drug Discovery Software Market Share by Country (2020-2031)
 Figure 49. Turkey Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Computational Medicine and Drug Discovery Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Entelos Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2020-2025)
 Figure 53. Genedata Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2020-2025)
 Figure 54. Crown Bioscience Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2020-2025)
 Figure 55. Biognos Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2020-2025)
 Figure 56. Chemical Computing Group Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2020-2025)
 Figure 57. Leadscope Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2020-2025)
 Figure 58. Nimbus Therapeutics Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2020-2025)
 Figure 59. Rhenovia Pharma Limited Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2020-2025)
 Figure 60. Schrodinger Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2020-2025)
 Figure 61. Compugen Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2020-2025)
 Figure 62. Dassault Systemes Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions